Clinical Trial: A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis

U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07158268) titled 'A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis' on Aug. 28.

Brief Summary: The primary objective of this study is to evaluate the efficacy of multiple-dose HSK47388 versus placebo in participants with moderate-to-severe plaque psoriasis.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Plaque Psoriasis

Intervention: DRUG: HSK47388

HSK47388 tablets will be administered orally, once a day

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Haisco Pharmaceutical Group Co., Ltd.

Published by HT Digital Content Services with permission fro...